These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adenoviruses as vectors for HIV vaccines. Gómez-Román VR; Robert-Guroff M AIDS Rev; 2003; 5(3):178-85. PubMed ID: 14598567 [TBL] [Abstract][Full Text] [Related]
6. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
7. Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice. Wüest T; Both GW; Prince AM; Hofmann C; Löser P Vaccine; 2004 Jul; 22(21-22):2717-21. PubMed ID: 15246602 [TBL] [Abstract][Full Text] [Related]
8. BCG as a vector for the construction of multivalent recombinant vaccines. Gicquel B Biologicals; 1995 Jun; 23(2):113-8. PubMed ID: 7546653 [No Abstract] [Full Text] [Related]
9. Gene therapy progress and prospects: adenoviral vectors. St George JA Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy. Kim J; Cho JY; Kim JH; Jung KC; Yun CO Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522 [TBL] [Abstract][Full Text] [Related]
12. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors. Zepeda M; Wilson JM Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637 [TBL] [Abstract][Full Text] [Related]
13. Advances towards targetable adenovirus vectors for gene therapy. Einfeld DA; Roelvink PW Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045 [TBL] [Abstract][Full Text] [Related]
14. New serotypes of adenoviral vectors. Stone D; Lieber A Curr Opin Mol Ther; 2006 Oct; 8(5):423-31. PubMed ID: 17078384 [TBL] [Abstract][Full Text] [Related]
15. Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. Schagen FH; Ossevoort M; Toes RE; Hoeben RC Crit Rev Oncol Hematol; 2004 Apr; 50(1):51-70. PubMed ID: 15094159 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus vector-mediated gene transfer into stem cells. Kawabata K; Sakurai F; Koizumi N; Hayakawa T; Mizuguchi H Mol Pharm; 2006; 3(2):95-103. PubMed ID: 16579638 [TBL] [Abstract][Full Text] [Related]
18. Live viral vectors: construction of a replication-deficient recombinant adenovirus. Fooks AR Methods Mol Med; 2003; 87():37-50. PubMed ID: 12958448 [No Abstract] [Full Text] [Related]
19. [Significance of recombinant adenoviruses in experimental gene therapy]. Adám E; Nász I Orv Hetil; 1995 Apr; 136(15):755-61. PubMed ID: 7724208 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field. Majhen D; Calderon H; Chandra N; Fajardo CA; Rajan A; Alemany R; Custers J Hum Gene Ther; 2014 Apr; 25(4):301-17. PubMed ID: 24580050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]